Cargando…

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

Detalles Bibliográficos
Autores principales:	Tudor, D, Derrien, M, Diomede, L, Houimel, M, Drillet, A, Moog, C, Reynes, J, Lopalco, L, Bomsel, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767654/ http://dx.doi.org/10.1186/1742-4690-6-S3-P165

Ejemplares similares

Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
por: Duchemin, Maxence, et al.
Publicado: (2020)

IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
por: Duchemin, Maxence, et al.
Publicado: (2018)

The CH1α domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals
por: Khamassi, Marwa, et al.
Publicado: (2020)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

An IgA mimicry of IgG that binds polymeric immunoglobulin receptor for mucosa transcytosis
por: Mao, Changchuin, et al.
Publicado: (2020)

Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
por: Wei, Hao, et al.
Publicado: (2021)

IgA transcytosis and antigen recognition govern ovarian cancer immunity
por: Biswas, Subir, et al.
Publicado: (2021)

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life
por: Yates, N L, et al.
Publicado: (2013)

P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
por: Bomsel, M, et al.
Publicado: (2009)

Specific IgA Enhances the Transcytosis and Excretion of Hepatitis A Virus
por: Counihan, Natalie A., et al.
Publicado: (2016)

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
por: Xu, Lin, et al.
Publicado: (2021)

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
por: Nabi, Rafiq, et al.
Publicado: (2017)

In Men at Risk of HIV Infection, IgM, IgG1, IgG3 and IgA Reach the Human Foreskin Epidermis
por: Lemos, Maria P., et al.
Publicado: (2015)

Receptor-mediated transcytosis of IgA in MDCK cells is via apical recycling endosomes
Publicado: (1994)

A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients
por: Brombin, Chiara, et al.
Publicado: (2013)

Are anti-HIV IgAs good guys or bad guys?
por: Zhou, Mingkui, et al.
Publicado: (2014)

Calcitonin gene–related peptide inhibits Langerhans cell–mediated HIV-1 transmission
por: Ganor, Yonatan, et al.
Publicado: (2013)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults()
por: Collins, Andrea M., et al.
Publicado: (2013)

Comparison of the Specificities of IgG, IgG-Subclass, IgA and IgM Reactivities in African and European HIV-Infected Individuals with an HIV-1 Clade C Proteome-Based Array
por: Gallerano, Daniela, et al.
Publicado: (2015)

Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection
por: Yu, Huifeng, et al.
Publicado: (2008)

Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020)

P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay
por: Bonsignori, M, et al.
Publicado: (2009)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

IgG deposition in IgA nephropathy patients
por: Nasri, Hamid
Publicado: (2013)

Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

IgG4-Seronegative Autoimmune Pancreatitis and Sclerosing Cholangitis
por: Kahn, Allon, et al.
Publicado: (2015)

3D6 and 4B3: Recombinant expression of two anti-gp41 antibodies as dimeric and secretory IgA
por: Reinhart, David, et al.
Publicado: (2011)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
por: Jia, Manxue, et al.
Publicado: (2020)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Screening for the Detection of Toxoplasma gondii IgG, IgM and IgA in Females of Reproductive Age from Western Romania
por: Mihu, Alin Gabriel, et al.
Publicado: (2022)

Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
por: Fouda, Genevieve G., et al.
Publicado: (2016)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
por: Leroux-Roels, Geert, et al.
Publicado: (2013)

R: IgG deposition in IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5ep93apm80n4j6ppnq0p85svh2